BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Dicloxacillin

One of the PENICILLINS which is resistant to PENICILLINASE.

297+ PubMed studies analyzed · 19 RCTs · Evidence Score: 46.4

Research Domains

Dicloxacillin has been studied across 14 research domains including 🫘 Kidney, ✨ Skin & Hair, 🧠 Focus & Attention, 🫁 Liver & Detox, ❤️ Cardiovascular. The primary research focus is 🫘 Kidney with 9% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dicloxacillin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

piperacillin
2 shared targets
Penicillin
2 shared targets
cefotaxime
2 shared targets
effusol
2 shared targets
cefadroxil
2 shared targets
Cephaloridine
2 shared targets
Thioctic
2 shared targets
combretastatin
2 shared targets
Cefamandole
2 shared targets
Cefoperazone
2 shared targets
Loading evidence profile...

This evidence profile for Dicloxacillin is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.